Pre & Post COVID-19 Market Estimates-Global Pruritus Therapeutic Market 2020-2024 | Evolving Opportunities with Abbott Laboratories and Allergan Plc | Technavio

Technavio has announced the latest market research report titled Global Pruritus Therapeutic Market 2020-2024 (Graphic: Business Wire)

LONDON--()--The global pruritus therapeutic market is expected to grow by USD 3.63 billion as per Technavio. This marks a significant market slowdown compared to the 2019 growth estimates due to the impact of the COVID-19 pandemic in the first half of 2020. However, steady growth is expected to continue throughout the forecast period, and the market is expected to grow at a CAGR of almost 6%.

Request challenges and opportunities that influence COVID-19 pandemic - Request free sample pages of the pruritus therapeutic market

Read the 120-page report with TOC on "Pruritus Therapeutic Market Analysis Report by Type (Renal pruritus, Cholestatic pruritus, Hematologic pruritus, Endocrine pruritus, and Oncological pruritus), Geography (North America, Europe, APAC, and ROW), and the Segment Forecasts, 2020-2024".

The market is driven by the increasing prevalence of pruritus. In addition, the strong pipeline of expected launches is anticipated to boost the growth of the pruritus therapeutic market.

Pruritus occurs in various disease conditions such as hematology, renal, cholesteric, endocrine, and oncology. Nearly 12 million people in the US have psoriasis and about 7.5 million are diagnosed with one or the other form of skin diseases that is accompanied by this condition. Also, currently, no specific medication is available for the treatment of prurigo nodularis. Its growing prevalence is providing significant growth opportunities for market vendors to engage in the development of novel pruritus therapeutics. This, in turn, is driving the growth of the global pruritus market.

Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.

View market snapshot before purchasing

Major Five Pruritus Therapeutic Companies:

Abbott Laboratories

Abbott Laboratories operates its business through segments such as Established Pharmaceuticals Products, Nutritional Products, Diagnostic Products, and Medical Devices. The company offers Humira, which is an injectable drug that is used to treat adults with moderate to severe chronic plaque psoriasis.

Allergan Plc

Allergan Plc operates its business through segments such as US Specialized Therapeutics, US General Medicine, and International. The company offers TAZORAC. It is a retinoid indicated for the topical treatment of plaque psoriasis.

Astellas Pharma Inc.

Astellas Pharma Inc. operates its business through a unified business segment. The company offers Protopic. It is a tacrolimus ointment used as a therapeutic agent for atopic dermatitis.

Cipla Inc.

Cipla Inc. operates its business through segments such as Pharmaceuticals and New ventures. The company offers ZOFLUT Cream. It contains fluticasone propionate which has anti-inflammatory, antipruritic, and vasoconstrictive properties.

GlaxoSmithKline Plc

GlaxoSmithKline Plc operates its business through segments such as Pharmaceuticals, Consumer healthcare, and Vaccines. The company offers Fenistil, which is indicated for itchiness caused by dermatoses, urticaria, insect bites, sunburn, and superficial burns.

Register for a free trial today and gain instant access to 17,000+ market research reports.

Technavio's SUBSCRIPTION platform

Pruritus Therapeutic Market Type Outlook (Revenue, USD Billion, 2020-2024)

  • Renal pruritus
  • Cholestatic pruritus
  • Hematologic pruritus
  • Endocrine pruritus
  • Oncological pruritus

Pruritus Therapeutic Market Regional Outlook (Revenue, USD Billion, 2020-2024)

  • North America
  • Europe
  • APAC
  • ROW

Technavio’s sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more. Request a free sample report

Related Reports on Health Care Include:

Global Antiviral Drugs Market – Global antiviral drugs market by application (hepatitis, HIV, herpes, influenza, and others), MOA (reverse transcriptase inhibitors, protease inhibitors, entry/fusion inhibitors, immune system modulators, and others), and geographic landscape (Asia, Europe, North America, and ROW).

Global Chloroquine Market – Global chloroquine market by application (malaria, rheumatoid arthritis, and others) and geography (North America, Europe, and Asia and ROW).

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.


Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200

Release Summary

The pruritus therapeutic market size has the potential to grow by USD 3.63 billion during 2020-2024


Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200